It’s not so much the previous approvals per se, but rather the opportunity that massive differential pricing by geographies and intended purpose presents for arbitrage and parallel imports.
I know that many on this forum hold the view that insurance companies will willingly pay sky high prices for iPPS on the basis that any price lower than that of a TKR represents a saving, and possibly that is indeed the case in the US, but IMO that’s never going to happen in Australia, as it’s not how the system works. Nor do I think that iPPS will ever go on the PBR at the $2 - $3k per dose that’s being posited here, as the costs involved would break the health budget.
But if people are suffering serious pain because of OA, and can’t afford an available treatment because of the high costs involved, they’re going to look to their options, and get what they need wherever they can.
- Forums
- ASX - By Stock
- Ann: Paradigm AGM Presentation
It’s not so much the previous approvals per se, but rather the...
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
23.0¢ |
Change
0.010(4.55%) |
Mkt cap ! $80.45M |
Open | High | Low | Value | Volume |
23.0¢ | 23.0¢ | 21.0¢ | $185.1K | 837.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.225 |
1 | 30000 | 0.220 |
2 | 46173 | 0.215 |
6 | 133409 | 0.210 |
6 | 99200 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 10000 | 1 |
0.240 | 102682 | 6 |
0.245 | 60994 | 3 |
0.250 | 55844 | 3 |
0.255 | 27830 | 3 |
Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online